A citation-based method for searching scientific literature

Baohai Shao, Leila R Zelnick, Jake Wimberger, Jonathan Himmelfarb, John Brunzell, W Sean Davidson, Janet K Snell-Bergeon, Karin E Bornfeldt, Ian H de Boer, Jay W Heinecke. Arterioscler Thromb Vasc Biol 2019
Times Cited: 10







List of co-cited articles
23 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.
Tomas Vaisar, Subramaniam Pennathur, Pattie S Green, Sina A Gharib, Andrew N Hoofnagle, Marian C Cheung, Jaeman Byun, Simona Vuletic, Sean Kassim, Pragya Singh,[...]. J Clin Invest 2007
684
40

A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects.
Baohai Shao, Ian de Boer, Chongren Tang, Philip S Mayer, Leila Zelnick, Maryam Afkarian, Jay W Heinecke, Jonathan Himmelfarb. J Proteome Res 2015
31
40

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments.
Brendan MacLean, Daniela M Tomazela, Nicholas Shulman, Matthew Chambers, Gregory L Finney, Barbara Frewen, Randall Kern, David L Tabb, Daniel C Liebler, Michael J MacCoss. Bioinformatics 2010
30

Uremia alters HDL composition and function.
Michael Holzer, Ruth Birner-Gruenberger, Tatjana Stojakovic, Dalia El-Gamal, Veronika Binder, Christian Wadsack, Akos Heinemann, Gunther Marsche. J Am Soc Nephrol 2011
192
30

Alteration of HDL Protein Composition with Hemodialysis Initiation.
Ke Wang, Leila R Zelnick, Andrew N Hoofnagle, Tomas Vaisar, Clark M Henderson, Peter B Imrey, Cassianne Robinson-Cohen, Ian H de Boer, Yan-Ting Shiu, Jonathan Himmelfarb,[...]. Clin J Am Soc Nephrol 2018
14
30

Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography.
Scott M Gordon, Jingyuan Deng, L Jason Lu, W Sean Davidson. J Proteome Res 2010
153
20


Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.
Amit V Khera, Marina Cuchel, Margarita de la Llera-Moya, Amrith Rodrigues, Megan F Burke, Kashif Jafri, Benjamin C French, Julie A Phillips, Megan L Mucksavage, Robert L Wilensky,[...]. N Engl J Med 2011
20

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice.
Aaron Tward, Yu-Rong Xia, Xu-Ping Wang, Yi-Shou Shi, Christina Park, Lawrence W Castellani, Aldons J Lusis, Diana M Shih. Circulation 2002
332
20

Dysfunctional HDL and atherosclerotic cardiovascular disease.
Robert S Rosenson, H Bryan Brewer, Benjamin J Ansell, Philip Barter, M John Chapman, Jay W Heinecke, Anatol Kontush, Alan R Tall, Nancy R Webb. Nat Rev Cardiol 2016
350
20

Protection against atherogenesis in mice mediated by human apolipoprotein A-IV.
N Duverger, G Tremp, J M Caillaud, F Emmanuel, G Castro, J C Fruchart, A Steinmetz, P Denèfle. Science 1996
215
20

Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD.
Anjali Ganda, Laurent Yvan-Charvet, Yuan Zhang, Eric J Lai, Renu Regunathan-Shenk, Farah N Hussain, Rupali Avasare, Bibhas Chakraborty, Annie J Febus, Linda Vernocchi,[...]. J Mol Cell Cardiol 2017
22
20

Proteomic Characterization of High-Density Lipoprotein Particles from Non-Diabetic Hemodialysis Patients.
Nans Florens, Catherine Calzada, Frédéric Delolme, Adeline Page, Fitsum Guebre Egziabher, Laurent Juillard, And Christophe O Soulage. Toxins (Basel) 2019
5
40

Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.
Suguru Yamamoto, Patricia G Yancey, T Alp Ikizler, W Gray Jerome, Ryohei Kaseda, Brian Cox, Aihua Bian, Ayumi Shintani, Agnes B Fogo, Macrae F Linton,[...]. J Am Coll Cardiol 2012
139
20

HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach.
Alain Mangé, Aurélie Goux, Stéphanie Badiou, Laure Patrier, Bernard Canaud, Thierry Maudelonde, Jean-Paul Cristol, Jérôme Solassol. PLoS One 2012
55
20

Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study.
Evgenia Gourgari, Junfeng Ma, Martin P Playford, Nehal N Mehta, Radoslav Goldman, Alan T Remaley, Scott M Gordon. Cardiovasc Diabetol 2019
27
20

Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis.
R J M W Rennenberg, A G H Kessels, L J Schurgers, J M A van Engelshoven, P W de Leeuw, A A Kroon. Vasc Health Risk Manag 2009
287
20

Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes.
Antonio Junior Lepedda, Omar Lobina, Silvia Rocchiccioli, Gabriele Nieddu, Nadia Ucciferri, Pierina De Muro, Michela Idini, Hai Quy Tram Nguyen, Anna Guarino, Rita Spirito,[...]. J Diabetes Complications 2016
11
20

Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.
Hamid Moradi, Elani Streja, Moti L Kashyap, Nosratola D Vaziri, Gregg C Fonarow, Kamyar Kalantar-Zadeh. Nephrol Dial Transplant 2014
64
20

Serum amyloid A in uremic HDL promotes inflammation.
Thomas Weichhart, Chantal Kopecky, Markus Kubicek, Michael Haidinger, Dominik Döller, Karl Katholnig, Cacang Suarna, Philipp Eller, Markus Tölle, Christopher Gerner,[...]. J Am Soc Nephrol 2012
152
20

Kidney function is associated with an altered protein composition of high-density lipoprotein.
Katya B Rubinow, Clark M Henderson, Cassianne Robinson-Cohen, Jonathan Himmelfarb, Ian H de Boer, Tomas Vaisar, Bryan Kestenbaum, Andrew N Hoofnagle. Kidney Int 2017
26
20

HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients.
Kathrin Untersteller, Sabine Meissl, Markus Trieb, Insa E Emrich, Adam M Zawada, Michael Holzer, Eva Knuplez, Danilo Fliser, Gunnar H Heine, Gunther Marsche. J Lipid Res 2018
19
20


Reporting Sex and Sex Differences in Preclinical Studies.
Hong S Lu, Ann Marie Schmidt, Robert A Hegele, Nigel Mackman, Daniel J Rader, Christian Weber, Alan Daugherty. Arterioscler Thromb Vasc Biol 2018
6
16

Variability in Total Cholesterol Is Associated With the Risk of End-Stage Renal Disease: A Nationwide Population-Based Study.
Mee Kyoung Kim, Kyungdo Han, Eun Sil Koh, Hun-Sung Kim, Hyuk-Sang Kwon, Yong-Moon Park, Kun-Ho Yoon, Seung-Hwan Lee. Arterioscler Thromb Vasc Biol 2017
33
10

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial.
David M Charytan, Marc S Sabatine, Terje R Pedersen, KyungAh Im, Jeong-Gun Park, Armando Lira Pineda, Scott M Wasserman, Prakash Deedwania, Anders G Olsson, Peter S Sever,[...]. J Am Coll Cardiol 2019
46
10

Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort).
Archna Bajaj, Scott M Damrauer, Amanda H Anderson, Dawei Xie, Matthew J Budoff, Alan S Go, Jiang He, James P Lash, Akinlolu Ojo, Wendy S Post,[...]. Arterioscler Thromb Vasc Biol 2017
28
10

Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).
Carla S B Viegas, Lúcia Santos, Anjos L Macedo, António A Matos, Ana P Silva, Pedro L Neves, An Staes, Kris Gevaert, Rute Morais, Cees Vermeer,[...]. Arterioscler Thromb Vasc Biol 2018
65
10

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, Kyungah Im, Erica L Goodrich, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Remo H M Furtado,[...]. Lancet 2019
10

Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council.
Peggy Robinet, Dianna M Milewicz, Lisa A Cassis, Nicholas J Leeper, Hong S Lu, Jonathan D Smith. Arterioscler Thromb Vasc Biol 2018
137
10

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association.
Connie B Newman, David Preiss, Jonathan A Tobert, Terry A Jacobson, Robert L Page, Larry B Goldstein, Clifford Chin, Lisa R Tannock, Michael Miller, Geetha Raghuveer,[...]. Arterioscler Thromb Vasc Biol 2019
179
10



Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease: An Emerging Role for Evolocumab?
David Z I Cherney, Robert S Rosenson, Patrick R Lawler. J Am Coll Cardiol 2019
5
20

A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes.
Monika A Niewczas, Meda E Pavkov, Jan Skupien, Adam Smiles, Zaipul I Md Dom, Jonathan M Wilson, Jihwan Park, Viji Nair, Andrew Schlafly, Pierre-Jean Saulnier,[...]. Nat Med 2019
120
10

Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association.
Alan Daugherty, Alan R Tall, Mat J A P Daemen, Erling Falk, Edward A Fisher, Guillermo García-Cardeña, Aldons J Lusis, A Phillip Owens, Michael E Rosenfeld, Renu Virmani. Arterioscler Thromb Vasc Biol 2017
170
10

High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality.
Helena Grauen Larsen, Goran Marinkovic, Peter M Nilsson, Jan Nilsson, Gunnar Engström, Olle Melander, Marju Orho-Melander, Alexandru Schiopu. Arterioscler Thromb Vasc Biol 2019
14
10

Lipid management in patients with chronic kidney disease.
Charles J Ferro, Patrick B Mark, Mehmet Kanbay, Pantelis Sarafidis, Gunnar H Heine, Patrick Rossignol, Ziad A Massy, Francesca Mallamaci, Jose M Valdivielso, Jolanta Malyszko,[...]. Nat Rev Nephrol 2018
66
10

APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension).
Teresa K Chen, Lawrence J Appel, Morgan E Grams, Adrienne Tin, Michael J Choi, Michael S Lipkowitz, Cheryl A Winkler, Michelle M Estrella. Arterioscler Thromb Vasc Biol 2017
27
10

Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases.
Arthur P Arnold, Lisa A Cassis, Mansoureh Eghbali, Karen Reue, Kathryn Sandberg. Arterioscler Thromb Vasc Biol 2017
127
10

Evolocumab in Patients with Cardiovascular Disease.
Marc S Sabatine, Robert P Giugliano, Terje R Pedersen. N Engl J Med 2017
21
10

Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study.
Hillary A Keenan, Tina Costacou, Jennifer K Sun, Alessandro Doria, Jerry Cavellerano, Joseph Coney, Trevor J Orchard, Lloyd Paul Aiello, George L King. Diabetes Care 2007
111
10




High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus.
Yi He, Vishal Kothari, Karin E Bornfeldt. Arterioscler Thromb Vasc Biol 2018
27
10


Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics.
Graziella E Ronsein, Nathalie Pamir, Priska D von Haller, Daniel S Kim, Michael N Oda, Gail P Jarvik, Tomas Vaisar, Jay W Heinecke. J Proteomics 2015
120
10

Characterization of human high-density lipoproteins by gradient gel electrophoresis.
P J Blanche, E L Gong, T M Forte, A V Nichols. Biochim Biophys Acta 1981
555
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.